UNSPSC 51282807: Telithromycin

This classification denotes a macrolide antibiotic with the molecular formula C43H65N5O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KI8H7H19WL, chemically known as erythromycin, 3-de((2,6-dideoxy-3-c-methyl-3-o-methyl-alpha-l-ribo-hexopyranosyl)oxy)-11,12-dideoxy-6-o-methyl-3-oxo-12,11-(oxycarbonyl((4-(4-(3-pyridinyl)-1h-imidazol-1-yl)butyl)imino))- but generally known as telithromycin, which bears US NIH Compound Identifier 3002190.

UNSPSC 51282807 Telithromycin, a Commodity code, shows minimal relevant recent state and local procurement activity. The code nominally describes a specific antibiotic pharmaceutical, but the recent opportunities posted under it involve naloxone (an opioid antagonist), medical and first aid supplies for emergency response, generic multi-source pharmaceuticals and OTC products through cooperative purchasing, and direct-to-manufacturer prescription program design—none of which are telithromycin or closely related therapeutics. The scope mismatch suggests this code is either rarely applied to actual telithromycin procurement or has been tagged inconsistently by issuing bodies.

The issuing-body mix spans county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), city purchasing departments (City of Tampa), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, which includes Oregon). Representative recent opportunities include Seminole County's IFB60459723LAS for naloxone and drug deactivation systems (response due July 26, 2023), the City of Tampa's IFB 26P00145 for medical and first aid supplies to the Fire Department Rescue Division with an estimated contract value of $700,000 (due March 13, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products (due March 26, 2026). Geographic activity appears concentrated in Florida and the upper Midwest with multi-state cooperative coverage. Given the disconnect between the code's nominal pharmaceutical description and the actual work being solicited, this code warrants verification of correct UNSPSC classification before pursuing opportunities posted under it.